HomeELAN • NYSE
Elanco Animal Health Inc
$12.95
Apr 19, 4:00:03 PM GMT-4 · USD · NYSE · Disclaimer
Top loserStockUS listed security
Previous close
$13.57
Day range
$12.69 - $13.49
Year range
$7.88 - $16.88
Market cap
6.38B USD
Avg Volume
3.70M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
1.04B5.08%
Operating expense
504.00M-0.40%
Net income
-141.00M-161.11%
Net profit margin
-13.62-148.54%
Earnings per share
0.08-57.89%
EBITDA
134.00M0.00%
Effective tax rate
-11.02%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
352.00M2.03%
Total assets
14.36B-7.29%
Total liabilities
8.14B-0.77%
Total equity
6.22B
Shares outstanding
492.97M
Price to book
1.07
Return on assets
0.30%
Return on capital
0.35%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-141.00M-161.11%
Cash from operations
157.00M1,107.69%
Cash from investing
-35.00M53.95%
Cash from financing
-139.00M-65.48%
Net change in cash
-17.00M85.22%
Free cash flow
199.75M311.66%
About
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
Founded
1954
Website
Employees
9,550
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu